Summit Therapeutics said its closely tracked antibody, the first lung cancer drug to beat Merck’s Keytruda in a head-to-head ...

A Cancer Gene Therapy study reveals that MEOX2 promotes lung cancer progression while SMARCB1 acts as a tumor suppressor, ...

Anti-aging aficionados have tried it all — including taking certain drugs off-label in the hopes they will lead to longer, ...

A cocktail of FDA-approved cancer drugs, trametinib and rapamycin, boosts the lifespan of lab mice by 30% and might help ...

In a new study out this week, scientists report that a combination of two existing cancer drugs — rapamycin and trametinib — ...

The American Institute of Cancer Research recommends a diet filled with a variety of fruits, vegetables, grains and ...

Prior studies have found strong links between marijuana use and later cardiovascular disease. A February 2024 study found smoking, vaping or eating marijuana led to a significantly higher risk of ...

A team from the Montreal Clinical Research Institute has identified a protein that could play a role in the spread of breast ...

French biochemist Raphaël Rodriguez co-developed an experimental drug targeting metastasis-the spread of cancer responsible ...

This study identifies 53BP1 as an interaction partner of GMCL1 (a likely CUL3 substrate receptor). The study seeks to link this finding to regulation of the mitotic surveillance pathway and paclitaxel ...

Radon is the second-leading cause of lung cancer, but now a researcher at NOSM University in Sudbury is investigating if ...

Microplastics are ubiquitous in the environment, and we all routinely inhale these tiny pollutants. Now new research ...